ZS

Emerging pharma companies need technology foundations that can support launch needs today and scale with the business tomorrow.

On this podcast, leaders discuss how biopharma teams can make early platform decisions, balance AI ambition with readiness and build technology roadmaps that help teams move from insight to action.

The conversation also explores how platforms like ZAIDYN® can help embed trusted intelligence into everyday workflows.

🎧 Listen now: https://bit.ly/43HtZ62

AI has yet to improve decision quality for most Medicare Advantage plans. Faster analysis and better data haven’t changed how plan design decisions get made.

Teams still rely on episodic reviews and fragmented inputs while bids lock in high-stakes choices around benefits, enrollment and profitability.

Here’s how to use AI to shape decision-making: https://bit.ly/4a2vvDn